Curza, Inc.
Pharmaceutical company · Salt Lake City, Utah, United States
Curza, Inc. is a pharmaceutical company headquartered in Salt Lake City, Utah, United States. Its earliest recorded incorporation is in 2021. It has received 5 US government small-business research awards (SBIR/STTR) from health agencies, $10 million in total, most recently in 2024. It has reported private securities offerings to the US SEC, most recently $367,233 sold in a notice filed in 2023.
Curza at a glance
What does Curza do?
US government research funding
5 SBIR/STTR small-business research awards from US health agencies, $10.5 million in total (2016 to 2024). NIH funding came from the National Institute of Allergy and Infectious Diseases.
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $367,233 sold (2023).
Frequently asked questions about Curza
Where is Curza headquartered?
Curza, Inc. is headquartered in Salt Lake City, Utah, United States.
What does Curza do?
Curza, Inc. is a pharmaceutical company.
When was Curza founded?
The earliest incorporation on record for Curza, Inc. is in 2021, according to public company registers.
Similar companies
- iVeena Delivery Systems, Inc.Salt Lake City, Utah, United States
- Lipocine Inc.Salt Lake City, Utah, United States
- Usana Health Sciences IncSalt Lake City, Utah, United States
- Clene Inc.Salt Lake City, Utah, United States
- Q Therapeutics, Inc.Salt Lake City, Utah, United States
- Clene Nanomedicine, Inc.Salt Lake City, Utah, United States
- Specialty Medical Products Co.Salt Lake City, Utah, United States
- AbbVie Inc.North Chicago, Illinois, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences